1.Dukat M, Choi YN, Teitler M, Du Pre A, Herrick-Davis K, Smith C, Glennon RA.. (2001) The binding of arylguanidines at 5-HT(3) serotonin receptors: a structure-affinity investigation., 11 (12):[PMID:11412989][10.1016/s0960-894x(01)00291-8]
2.Dukat M, Abdel-Rahman AA, Ismaiel AM, Ingher S, Teitler M, Gyermek L, Glennon RA.. (1996) Structure-activity relationships for the binding of arylpiperazines and arylbiguanides at 5-HT3 serotonin receptors., 39 (20):[PMID:8831767][10.1021/jm9603936]
3.Zhou Y, Peng H, Ji Q, Qi J, Zhu Z, Yang C.. (2006) Discovery of small molecule inhibitors of integrin alphavbeta3 through structure-based virtual screening., 16 (22):[PMID:16982193][10.1016/j.bmcl.2006.08.061]
4.Tonelli M, Espinoza S, Gainetdinov RR, Cichero E.. (2017) Novel biguanide-based derivatives scouted as TAAR1 agonists: Synthesis, biological evaluation, ADME prediction and molecular docking studies., 127 [PMID:27823885][10.1016/j.ejmech.2016.10.058]
5.Tonelli M, Naesens L, Gazzarrini S, Santucci M, Cichero E, Tasso B, Moroni A, Costi MP, Loddo R.. (2017) Host dihydrofolate reductase (DHFR)-directed cycloguanil analogues endowed with activity against influenza virus and respiratory syncytial virus., 135 [PMID:28477572][10.1016/j.ejmech.2017.04.070]